Pfizer Limited (NSE:PFIZER)
3,902.10
-15.80 (-0.40%)
Nov 11, 2026, 1:20 PM IST
Pfizer Revenue
Pfizer had revenue of 7.27B INR in the quarter ending September 30, 2026, with 13.16% growth. This brings the company's total for the last twelve months to 26.54B, up 11.75% year-over-year. In the fiscal year ending March 31, 2026, Pfizer had annual revenue of 25.20B with 10.45% growth. That makes Pfizer the 14,939th largest company in the world by revenue and 776th in India.
Revenue (ttm)
26.54B
Revenue Growth
+11.75%
P/S Ratio
6.75
Revenue / Employee
21.34M
Employees
1,244
Market Cap
178.51B
Revenue by Geography
- India 24.23B 96.2%
- outside of India 963.40M 3.8%
Fiscal year ended Mar 31, 2026 See the full Pfizer breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 25.20B | 2.38B | 10.45% |
| Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
| Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
| Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
| Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Alembic Pharmaceuticals | 84.77B |
| Laurus Labs | 78.23B |
| Syngene International | 35.22B |
| Eris Lifesciences | 33.12B |
| Alivus Life Sciences | 26.84B |
Pfizer News
- 7 days ago - Pfizer Quarterly report: Q2 2027 - Filings
- 3 months ago - Pfizer Quarterly report: Q1 2027 - Filings
- 4 months ago - Pfizer announces Rs 75 per share final dividend with record date set for July 17, 2026 - Business Upturn
- 6 months ago - Pfizer Quarterly report: Q4 2026 - Filings
- 6 months ago - Pfizer Annual report: Q4 2026 - Filings
- 9 months ago - Pfizer Quarterly report: Q3 2026 - Filings
- 9 months ago - Pfizer appoints Nilesh Pendse as vaccines category lead; Manikantan Seshadrinathan exits senior management - Business Upturn
- 10 months ago - Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands - Business Upturn